Formats
PDF report
Free
1.5MB
Another format
If you need this publication in an alternative format, please contact us.
Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020
Publication
Release Date:
Topic: Chronic kidney disease
Citation
AIHW (Australian Institute of Health and Welfare) (2014) Projections of the prevalence of treated end-stage kidney disease in Australia 2012-2020, AIHW, Australian Government, accessed 24 June 2026.
PDF | 1.5MB
End-stage kidney disease (ESKD) is the most severe form of chronic kidney disease with patients usually requiring kidney replacement therapy in the form of dialysis or kidney transplantation to survive. Projections of the prevalence of treated end-stage kidney disease in Australia presents national level projections of the number of people receiving kidney replacement therapy for their ESKD for the period 2012 to 2020. This information is important for predicting the future burden of ESKD in Australia.
- ISBN: 978-1-74249-578-1
- Cat. no: PHE 176
- Pages: 59
Findings from this report:
-
The number of people receiving Kidney Replacement Therapy (KRT) for ESKD tripled between 1991 and 2011
-
The prevalence of treated ESKD is projected to rise by between 45 and 64% between 2011 and 2020
-
The prevalence is projected to double for those who start treatment when they are over 75 years
-
The prevalence of treated-ESKD with diabetes as a primary cause is projected to double between 2011 and 2020